MaxLinear, Inc. (NASDAQ:MXL) Receives $25.50 Average Price Target from Analysts

Shares of MaxLinear, Inc. (NASDAQ:MXL) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $22.36.

Several equities analysts have recently weighed in on the stock. Stifel Nicolaus cut their target price on shares of MaxLinear from $26.00 to $16.00 and set a “buy” rating for the company in a report on Thursday. Needham & Company LLC reiterated a “hold” rating on shares of MaxLinear in a research report on Thursday, January 30th. Benchmark dropped their target price on MaxLinear from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Tuesday, April 15th. Northland Securities upped their price target on MaxLinear from $25.00 to $27.50 and gave the stock an “outperform” rating in a report on Monday, January 6th. Finally, Susquehanna dropped their price objective on MaxLinear from $25.00 to $23.00 and set a “neutral” rating on the stock in a report on Thursday, January 30th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Weybosset Research & Management LLC raised its holdings in MaxLinear by 134.0% in the 1st quarter. Weybosset Research & Management LLC now owns 216,971 shares of the semiconductor company’s stock valued at $2,356,000 after acquiring an additional 124,240 shares during the last quarter. GAMMA Investing LLC increased its position in MaxLinear by 889.1% during the first quarter. GAMMA Investing LLC now owns 40,888 shares of the semiconductor company’s stock worth $444,000 after purchasing an additional 36,754 shares during the last quarter. Wellington Management Group LLP acquired a new position in MaxLinear in the 4th quarter valued at about $3,709,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of MaxLinear by 5.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 147,210 shares of the semiconductor company’s stock valued at $2,912,000 after buying an additional 7,711 shares during the period. Finally, Two Sigma Advisers LP increased its holdings in shares of MaxLinear by 29.2% during the 4th quarter. Two Sigma Advisers LP now owns 896,549 shares of the semiconductor company’s stock worth $17,734,000 after buying an additional 202,400 shares during the last quarter. 90.79% of the stock is owned by institutional investors and hedge funds.

MaxLinear Trading Up 0.7 %

NASDAQ MXL opened at $10.22 on Friday. The company has a fifty day moving average of $12.71 and a 200 day moving average of $15.86. The company has a market capitalization of $864.96 million, a PE ratio of -3.49 and a beta of 1.82. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.28. MaxLinear has a 1 year low of $8.35 and a 1 year high of $26.59.

MaxLinear (NASDAQ:MXL) last issued its earnings results on Wednesday, January 29th. The semiconductor company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.14). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. Research analysts forecast that MaxLinear will post -0.37 earnings per share for the current year.

About MaxLinear

MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.